Michaël Bernier1,2, Olivia Viessmann1,2, Ned Ohringer1, Jingyuan E. Chen1,2, Nina E. Fultz1,3, Rebecca Karp Leaf4, Lawrence L. Wald1,2,5, and Jonathan R. Polimeni1,2,5
1Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States, 2Radiology, Harvard Medical School, Boston, MA, United States, 3Engineering, Boston University, Boston, MA, United States, 4Division of Hematology, Massachusetts General Hospital, Boston, MA, United States, 55Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, United States
Synopsis
Ferumoxytol—a safe,
superparamagnetic iron oxide nanoparticle that amplifies T2*
dephasing in blood vessels—can be used as a powerful image contrast enhancement
agent to aid vascular imaging. Combining this with an innovative vascular segmentation
tool, here we evaluate how Ferumoxytol improves vascular detection throughout
the brain using a region-based analysis of the gray-matter and a
bundle-specific analysis of the white-matter. We report increases in
white-matter vasculature specificity and uncover spatial patterns similar to
white-matter tracts, therefore this work sheds new light on the possible
existence and influence of a concurrent network of vasculature that follows the
known fiber bundles.
INTRODUCTION
Cerebral vascular imaging
provides crucial information in clinical research to study vascular impairment
in healthy and diseased brain function, but also in neuroscientific research to
assess vascular biases in fMRI methods [1]. However, human in
vivo imaging technologies are currently limited in terms of their capacity
to measure the smaller vessels of the cerebrovasculature (< 200 μm) [2], amongst them white-matter vessels, and thus our understanding
of the pathophysiology of the many white-matter diseases with vascular
underpinnings is limited. To overcome this, Ferumoxytol, a safe iron supplement
administered intravenously [3], can be used as an MR blood-pool contrast agent to
improve detection of white matter vessels. It provides a long (~12-hour)
half-life, strong T1 and T2* shortening, and no extravasation
into surrounding tissues [4], [5]. Ferumoxytol could therefore help investigate the cortical, subcortical, and deep
white matter (WM) arteries or deep medullary veins usually observed post-mortem
or at high field MRI [6]–[8], allowing for an improved detection of the brain vasculature
throughout all tissue types or for a better measurement of vascular defect in
the deep WM vessels [9]. Given this, our main objectives were to (1) explore
the vascular detection and segmentation improvements provided by Ferumoxytol,
in order to (2) find small vessels normally undetected in all tissues including
the WM without contrast agent and, (3) quantify the vascular densities across
different gray-matter (GM) regions and WM fiber-bundles.METHODS
Using a Siemens TimTrio 3T scanner, pre- and post-injection with 510 mg
of Ferumoxytol, four anemic but neurologically healthy (44 ± 7 y.o., 3F)
underwent MRI sessions (one day apart) consisting of an anatomical T1-weighted
MP2RAGE acquisition (TR/TI1/TI2/TE=5000/700/2500/2.5 ms, voxel size 1 mm³ iso.),
a 15-minute whole-head 3D T2* multi-echo GRE acquisition (192×192×96
mm FOV, 7 echoes, TR/TEs=2000/4.88/9.76/14.64/19.52/24.40/29.28/34.16 ms, voxel
size 0.6 mm³ iso., flip angle=17°). All pre- and post-injection images were
non-linearly coregistered symmetrically to their mid-point (T2*-mid
and T1-mid). The T2*-mid pre- and post-images were then
non-linearly coregistered to corresponding T1-mid pre- and
post-images using ANTs [10]. The T1-mid pre anatomical
image was segmented using FreeSurfer and non-linearly registered to the MNI
space to allow a back-projection of the IIT 5.0 WM bundle atlas (obtained from
RecoBundle [11], [12]) each subject. This resulted in 82 GM
regions and 24 WM bundles (contiguous
overlapping 3D masks representing specific major fiber bundles) in subject space. All ME-GRE echoes
were individually denoised using non-local means (NLM), N4 bias-corrected and
skull-stripped using ANTs. Vascular segmentation was performed on all echoes using
an updated Braincharter segmentation tool [13], limited to a diameter range between
0.5 and 3.0 mm, which generated a "vesselness" score that was then thresholded
at >95% to obtain a fine vessel tree. GM vessels were identified as those
above the WM surface, and WM vessels were identified as those within a bundle
ROI.RESULTS
Figure 1 illustrates the segmentation results for a single subject; Ferumoxytol
allowed an enhanced depiction of the vasculature, especially within the WM.
Figure 2 shows the regional vascular density for both the GM and WM, calculated
at the group level, with and without the contrast agent. In the WM, an increase
(an average of 3.76 times more) was observed for all bundles tested. Even
though our sample size is limited, the vascular density was consistent amongst
the subjects. Figure 3 shows the spatial patterns of the vasculature from a
small subset of selected WM bundles with the highest density.DISCUSSION & CONCLUSION
Although the vascular
density varied differently from region to region with Ferumoxytol, the global
spatial pattern of the GM vascular distribution agrees with the pattern without
Ferumoxytol and with our previous study [13]. Several WM bundles exhibited a higher vascular
density than others. Surprisingly, the fornix was found highly vascularized,
which could be caused by its relatively smaller size compared to the other
bundles. In several bundles the spatial pattern of the vessels qualitatively appears to follow the coarse-scale
geometry of the fibers. While this requires validation, if true this finding may
help inform our interpretation of the geometry of fiber bundles estimated from
diffusion MRI—since luminal signal from slow blood flow may impact the apparent diffusion coefficient at low b-values, and vessel
walls themselves might hinder and restrict tissue water diffusion for higher b-values [14]. A limitation of our
study is that these data cannot distinguish between a bundle having larger
vessels compared to many sub-voxel vessels. Nevertheless, our white matter atlas, the first created from in vivo data, could provide valuable
information regarding the anatomical relationships between the white matter
vasculature and fiber bundles, especially as it
is possible to exhibit extensive vascular injury without adjacent axonal injury [15].Acknowledgements
This work was
supported in part by the NIH NIBIB (grants P41-EB015896 and R01-EB019437),
NINDS (grant R21-NS106706), by the BRAIN
Initiative (NIH NIMH grant R01-MH111419), and by the MGH/HST Athinoula A.
Martinos Center for Biomedical Imaging; and was made possible by the resources provided
by NIH Shared Instrumentation Grants S10-RR023043 and S10-RR019371. We thank
our colleagues at Siemens Heathineers for use of the Works-In-Progress package
#944, and Dr. Brian Edlow for sharing his thoughts on clinical applications.References
[1] S. M. Kazan et al., “Vascular
autorescaling of fMRI (VasA fMRI) improves sensitivity of population studies: A
pilot study.,” Neuroimage, vol. 124, no. Pt A, pp. 794–805, Jan. 2016.
[2] M. Marín-Padilla, “The human brain
intracerebral microvascular system: development and structure,” Front.
Neuroanat., vol. 6, p. 38, Sep. 2012.
[3] K.-L. Nguyen et al., “Multicenter
Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI,” Radiology,
p. 190477, Oct. 2019.
[4] A. M. Muehe et al., “Safety Report
of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.,” Invest.
Radiol., vol. 51, no. 4, pp. 221–227, Apr. 2016.
[5] E. A. Neuwelt et al., “The
potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion,
and angiography in central nervous system malignancy: A pilot study,” Neurosurgery,
vol. 60, no. 4, pp. 601–611, Apr. 2007.
[6] H. Nonaka, M. Akima, T. Hatori, T.
Nagayama, Z. Zhang, and F. Ihara, “Microvasculature of the human cerebral white
matter: Arteries of the deep white matter,” Neuropathology, vol. 23, no.
2, pp. 111–118, 2003.
[7] T. P. Naidich, H. M. Duvernoy, B. N.
Delman, A. G. Sorensen, S. S. Kollias, and E. M. Haacke, Duvernoy’s Atlas of
the Human Brain Stem and Cerebellum. Vienna: Springer Vienna, 2009.
[8] H. J. Kuijf et al., “Quantification
of deep medullary veins at 7 T brain MRI,” Eur. Radiol., vol. 26, no.
10, pp. 3412–3418, Oct. 2016.
[9] Y. Hase et al., “White matter
capillaries in vascular and neurodegenerative dementias,” Acta Neuropathol.
Commun., vol. 7, no. 1, p. 16, Dec. 2019.
[10] B. Avants, N. Tustison, and G. Song, “Advanced
Normalization Tools (ANTS),” Insight J., pp. 1–35, 2009.
[11] E. Garyfallidis et al., “Recognition
of white matter bundles using local and global streamline-based registration
and clustering,” Neuroimage, vol. 170, pp. 283–295, Apr. 2018.
[12] S. Zhang and K. Arfanakis, “Evaluation of
standardized and study-specific diffusion tensor imaging templates of the adult
human brain: Template characteristics, spatial normalization accuracy, and
detection of small inter-group FA differences,” Neuroimage, vol. 172,
pp. 40–50, May 2018.
[13] M. Bernier, S. C. Cunnane, and K.
Whittingstall, “The morphology of the human cerebrovascular system,” Hum.
Brain Mapp., vol. 39, no. 12, pp. 4962–4975, Dec. 2018.
[14] P. Heusch et al., “Impact of blood
flow on diffusion coefficients of the human kidney: A time-resolved
ECG-triggered diffusion-tensor imaging (DTI) study at 3T,” J. Magn. Reson. Imaging,
vol. 37, no. 1, pp. 233–236, Jan. 2013.
[15] A. D. Griffin et al., “Traumatic
microbleeds suggest vascular injury and predict disability in traumatic brain
injury,” Brain, pp. 1–15, Oct. 2019.